Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 17Prostate Cancer Metastatic 3Neoplasms 3Stomach Neoplasms 2Neoplasm Metastasis 2Carcinoma, Transitional Cell 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Metastatic Breast Cancer With Intracranial Metastases 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1Hormone-Resistant Prostate Cancer 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 235Pemetrexed 214Paclitaxel 160Cisplatin 150pembrolizumab 145Erlotinib Hydrochloride 141Docetaxel 133Gemcitabine 94Bevacizumab 85Nivolumab 72Radiotherapy 62atezolizumab 40Radiosurgery 37Afatinib 37osimertinib 35130-nm albumin-bound paclitaxel 35Cetuximab 34durvalumab 33Ipilimumab 32Gefitinib 31Albumin-Bound Paclitaxel 29Vinorelbine 23Taxes 22Etoposide 20Crizotinib 19Radiation 17Sorafenib 16Cyclophosphamide 16Dexamethasone 15Magnetic Resonance Spectroscopy 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Non-Small-Cell Lung × cabazitaxel × Clear all
NCT01438307 2017-05-24

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

University of Alabama at Birmingham

Phase 2 Completed
28 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡